Hair Transplant Long Island New York Surgeon: Why Dr. Roy Stoller’s ARTAS Robotic Expertise and 6,000-Procedure Record Make Him the Region’s Benchmark Choice

Introduction: Why Choosing the Right Hair Transplant Surgeon on Long Island Demands More Than a Google Search

Androgenetic alopecia, the clinical term for pattern hair loss, affects an estimated 50 million men and 30 million women across the United States, according to research presented at the 2025 American Academy of Dermatology Innovation Academy (Dermatology Times). On Long Island, with its aging, high-income suburban population and proximity to New York City, that statistic translates into one of the largest concentrations of potential hair restoration patients in the country. For anyone in Nassau or Suffolk County beginning the search for a hair transplant Long Island New York surgeon, the decision carries far more weight than a quick scan of star ratings.

The stakes are real and growing. According to the ISHRS 2025 Practice Census, repair cases (procedures to correct prior botched transplants) rose to 10% of all cases, up from 6% in 2021, and 59% of ISHRS members reported black-market hair transplant clinics operating in their cities (Shapiro Medical Group). Choosing the wrong provider can mean permanent donor area damage, unnatural results, and the cost of corrective surgery.

This article does not rank surgeons by directory reviews. Instead, it evaluates them against a structured set of objective criteria: board certifications, technology access, procedural volume, academic standing, and geographic accessibility. The subject of the case being built here is Dr. Roy Stoller, a surgeon with more than 20 years of dedicated experience, more than 6,000 procedures performed, ARTAS robotic capability, and a patented RS Laser Cap. By the end, a high-intent reader will have a defensible, evidence-based framework for making a surgeon decision.

The Five Criteria That Separate Elite Hair Transplant Surgeons from the Rest

A credible evaluation requires consistent standards. The following five criteria are applied to Dr. Stoller and each named Long Island competitor throughout this article.

1. Board certification in a relevant surgical specialty. Facial plastic surgery, otolaryngology, or plastic surgery certification signals demonstrated surgical competency, not merely a general medical license.
2. Procedural volume and experience. The ISHRS identifies surgeon experience as the single most critical success factor. A record of 6,000-plus procedures represents a meaningful benchmark.
3. Access to advanced technology. FDA-cleared robotic FUE systems such as ARTAS reduce human variability and support strong graft survival rates.
4. Academic and professional standing. Authoring board certification exams, presenting at international conferences, and serving on ethics committees signal peer-recognized expertise.
5. Geographic accessibility and multi-modality treatment. A surgeon offering FUT, FUE, robotic FUE, laser therapy, SMP, and non-surgical options is categorically different from a single-technique specialist.

Dr. Roy Stoller: A Credential-by-Credential Profile

Dr. Roy B. Stoller is a Doctor of Osteopathy and a board-certified facial plastic surgeon. He is board-certified in Otolaryngology and Facial Plastic Surgery by the American Osteopathic Board, and he holds Fellowship status in Facial Plastic Surgery approved by both the American Medical Association and the American Osteopathic Association.

His academic formation is rigorous. He graduated from The New York Institute of Technology College of Osteopathic Medicine in 1985 and completed his residency at The Hospital of Philadelphia College of Osteopathic Medicine. Over the following decades, he focused his practice on hair restoration, accumulating more than 20 years of dedicated experience and surpassing the 6,000-procedure milestone, a volume that places him in a rare tier nationally.

Dr. Stoller is more than a practitioner. He has authored and examined for the board certification exam for facial plastic surgeons, making him a standard-setter for the field. He is a member of the International Society of Hair Restoration Surgery (ISHRS), where he has served on the Ethics Committee and conducted FUE workshops (MyHair.ai ISHRS Directory). He has been recognized as a top 1% physician by Vitals Top 10 Doctors and is a Fellow of the American Academy of Otolaryngology/Head and Neck Surgery. Before launching his private practice, he served as Medical Director of one of the nation’s largest hair restoration centers, an institutional-scale background that informs his approach to complex cases.

The ARTAS Robotic FUE Advantage: What It Means for Long Island Patients

ARTAS is an FDA-cleared robotic system that uses AI-assisted imaging to perform Follicular Unit Extraction with a precision that reduces human variability. The technology benefits are quantifiable: the ARTAS iX system uses AI to assist surgeons in FUE with higher precision and reduces procedure time by approximately 20%. Robotic FUE systems can achieve graft survival rates in the upper 90th percentile under experienced direction.

For patients, the advantages are tangible. There is no linear scar, which allows short hairstyles after the procedure. Recovery is minimally invasive, and consistent follicle selection protects the integrity of the donor area. These benefits become especially important at high graft volumes. Dr. Stoller performs sessions of 3,000-plus grafts, well above the 2024 industry average of 2,347 grafts per first-time procedure (Wimpole Clinic). At that scale, robotic precision protects both yield and donor health.

Critically, Dr. Stoller is among the only board-certified plastic surgeons on Long Island and in the New York metro area utilizing the ARTAS Robotic System (WebMD). The broader market reflects the value of this capability: rising adoption of robotic systems like the ARTAS iXi is a key driver of global hair transplant market growth.

The RS Laser Cap: Dr. Stoller’s Patented Innovation and What It Signals About His Practice

Beyond surgical technique, Dr. Stoller invented and patented the RS Laser Cap, a low-level light therapy (LLLT) delivery system designed to stimulate follicular regrowth. A patent matters in a clinical context because it signals that he has not only mastered existing techniques but contributed original intellectual property to the field, a distinction no Long Island competitor can claim.

The RS Laser Cap also connects to a broader treatment spectrum. Patients who are not yet surgical candidates, or who want to preserve existing hair between procedures, benefit from a surgeon who has innovated in this space. LLLT is used both before and after surgery to optimize scalp health and support graft survival. This is increasingly relevant: non-surgical hair restoration patients are up 29.7% since 2021 (Wimpole Clinic). Surgeons who invent and patent devices are operating at the frontier of their specialty, not simply performing commoditized procedures.

The Full Spectrum of Services: Why Treatment Breadth Matters for Long-Term Outcomes

Dr. Stoller offers a complete treatment menu: FUT, FUE, ARTAS Robotic FUE, RS Laser Cap therapy, ACP (autologous conditioned plasma), scalp micropigmentation (SMP), and cellular micrografting.

Breadth matters because hair loss is progressive. A patient’s needs at age 30 differ from their needs at 45, and a surgeon offering only one technique cannot adapt to an evolving situation. FUT availability alongside FUE is especially significant, since FUT allows high graft yield in single sessions and remains the preferred technique for certain hair loss patterns. A surgeon who performs only FUE limits patient options.

The female patient opportunity is also growing. Female surgical patients increased 16.5% from 2021 to 2024, a demographic many Long Island competitors largely ignore but that Dr. Stoller’s full-spectrum practice is equipped to evaluate and treat. Facial hair restoration is another expanding niche: the global beard transplant market reached roughly $243 million in 2025 and is projected to approach $797 million by 2032, with New York City at the epicenter of demand. The ISHRS identifies comprehensive evaluation and individualized treatment planning as hallmarks of ethical, high-quality care, and Dr. Stoller’s service menu reflects exactly that standard.

Geographic Accessibility: Long Island, Manhattan, and New Jersey Under One Surgeon

Dr. Stoller maintains a multi-location practice spanning Long Island, New York City (Madison Avenue), and New Jersey, making him accessible to the entire New York metro patient population. For Long Island patients specifically, this means Nassau and Suffolk County residents can access him locally without commuting into Manhattan, while still having the option of his NYC location for consultations.

Long Island’s suburban demographic, characterized by high household incomes and an aging population, represents an ideal market for premium hair restoration. Dr. Stoller’s local presence directly serves this community. By contrast, competitors operating from a single location introduce scheduling friction and reduce continuity of care across the treatment journey. The New York metro area is considered one of the top markets nationally for hair restoration due to surgeon expertise and patient demand, and Dr. Stoller’s footprint across this geography positions him uniquely.

Competitor Gap Analysis: How Dr. Stoller Compares to Named Long Island Surgeons

The following comparison is structured and evidence-based. It is not a dismissal of competitors but an identification of capability gaps relevant to patient decision-making, and a tool to help patients ask the right questions of any surgeon they consult, including Dr. Stoller.

Dr. James Marotta (Marotta Hair Restoration, Smithtown): Strong Brand, Missing Robotic Technology

Dr. Marotta is a dual board-certified facial plastic surgeon, trained at Columbia, SUNY Stony Brook, and Yale, and recognized as “Best Cosmetic Surgeon on Long Island” for over a decade. The critical gap is technology. There is no mention of the ARTAS Robotic System or any equivalent robotic FUE in his practice, and no patented proprietary device comparable to the RS Laser Cap. For patients who are candidates for robotic FUE, particularly those wanting short hairstyles or with complex donor considerations, this gap does not exist with Dr. Stoller. Strong brand recognition does not substitute for technology that materially affects outcomes.

LA FUE Hair New York (Dr. Anton Georgiev): FUE Specialization Without Surgical Breadth

LA FUE Hair operates in both Long Island and Manhattan with strong FUE-focused branding and a national network affiliation. The primary gap is breadth: an exclusive FUE focus means no FUT option, no robotic system, and no laser therapy. A surgeon who performs only one technique may be predisposed to recommend it regardless of whether it is optimal for a given patient’s anatomy. There is also less emphasis on facial plastic surgery board certification compared to Dr. Stoller’s dual-board status. The ISHRS standard of individualized treatment planning, rather than technique-first thinking, favors a full-spectrum practice.

Maxim Hair Restoration (Long Island): Corporate Volume vs. Private Practice Expertise

Maxim offers accessible locations. The structural gap is its model: a corporate multi-location chain rather than a private practice led by a single surgeon with a defined credential profile and personal accountability. Patients at corporate chains frequently report feeling like “just a number,” a pain point Dr. Stoller’s patients cite as a reason for choosing his practice. There is no evidence of ARTAS robotic capability or proprietary devices, and corporate chains rarely feature surgeons who author board exams, serve on ISHRS ethics committees, or present internationally. The rise of franchise models is part of the environment in which patient safety standards vary, making individual surgeon credentials more important, not less.

Dr. Greenberg (Greenberg Cosmetic Surgery): Hair Restoration as a Secondary Service

Greenberg Cosmetic Surgery offers multi-location presence across Long Island and NYC, a logistical strength. The fundamental gap is focus: hair restoration appears to be one of many cosmetic services rather than the primary specialty. Surgeons who dedicate their practice primarily to hair restoration accumulate procedural volume and technique refinement that generalists cannot match. There is no evidence of ARTAS capability. Dr. Stoller’s 6,000-plus procedures in a focused specialty is categorically different from high volume spread across mixed cosmetic services. When hair restoration is the primary concern, patients deserve a surgeon for whom it is the primary focus.

Additional Competitors: Dr. Alizadeh and Dr. Robert Dorin

Dr. Alizadeh (Cosmoplastic Surgery, NYC/Long Island) is Cornell and University of Chicago-trained with 3,500-plus cases, a notable profile. However, the practice has no ARTAS robotic system and no patented technology, and the case volume, while meaningful, is materially below Dr. Stoller’s 6,000-plus milestone. Dr. Robert Dorin (The Hair Loss Doctors, NYC) holds a national reputation as one of the “World’s Top 35 Hair Transplant Surgeons” since 2020, but offers less Long Island-specific accessibility and no robotic ARTAS option. Across all named competitors, the consistent gaps are robotic technology, proprietary innovation, academic exam authorship, and ISHRS Ethics Committee service, all documented advantages for Dr. Stoller.

The Black Market Risk: Why Board Certification and ISHRS Membership Are Non-Negotiable

The ISHRS 2025 Practice Census found that 59% of members reported black-market hair transplant clinics in their cities, with repair cases rising to 10% of all procedures, up from 6% in 2021. In this context, “black market” means unqualified practitioners, overharvesting of donor areas, unsanitary conditions, and absent post-operative care.

The density of the New York population and high demand create conditions in which unqualified providers attract patients through aggressive marketing. ISHRS membership matters because members are held to published clinical practice guidelines and ethical standards. Ethics Committee service, which Dr. Stoller provides, represents active enforcement of those standards. Board certification in facial plastic surgery or otolaryngology requires demonstrated surgical competency, ongoing education, and peer review. These are not self-designated titles. With one in ten procedures now a repair case, credential verification is a practical patient safety framework, not an academic exercise.

Who Is the Ideal Patient for Dr. Stoller’s Long Island Practice?

• Men with androgenetic alopecia at any stage, from early onset (95% of first-time surgical patients in 2024 were aged 20 to 35, per the ISHRS) to advanced pattern baldness.
• Women experiencing diffuse thinning or pattern hair loss, a segment up 16.5% from 2021 to 2024.
• Patients seeking repair or refinement of prior transplants, now 10% of all procedures nationally.
• Individuals seeking facial hair restoration (beard, eyebrow), a fast-growing niche centered in New York.
• Nassau and Suffolk County residents who want a locally accessible surgeon without sacrificing Manhattan-level expertise and technology.
• Patients wanting a single-surgeon relationship across the full journey, from consultation through surgery to non-surgical maintenance, rather than a corporate chain experience.
• High-profile individuals requiring discretion, natural results, and a documented track record at scale.

What to Expect: The Hair Restoration Journey with Dr. Stoller

For patients in the consideration phase, demystifying the process reduces anxiety. Procedures are performed while patients are awake and relaxed, with comfort amenities designed to make multi-hour sessions manageable. The typical graft range runs from 1,500 to 3,000-plus grafts per session, with Dr. Stoller’s capacity for larger sessions positioning him above the industry average for complex cases.

Timeline expectations should be realistic. Hair growth typically begins at three to four months, with full results visible at nine to twelve months. A minimum eight-month waiting period between procedures allows accurate assessment before additional work. A 2025 peer-reviewed study in the Journal of Cosmetic Dermatology confirmed that hair transplantation produces measurable improvements in self-esteem, confidence, and emotional well-being when expectations are properly managed, underscoring the importance of a thorough consultation. A peer-reviewed systematic review found overall weighted follicular unit graft survival rates of 82.7% at seven to twelve months, peaking at one year, while ARTAS robotic FUE achieves rates in the upper 90th percentile.

The Market Context: Why Now Is the Right Time for Long Island Patients to Act

The U.S. hair transplant market is projected to grow from $1.4 billion in 2025 to $4.0 billion by 2035, at a CAGR of roughly 10%. Demand is accelerating, not plateauing. The demographic urgency is clear: by age 35, about 40% of men show visible hair loss, climbing to 85% by age 50. Early intervention preserves more donor hair and produces more natural results, which helps explain why 95% of first-time surgical patients in 2024 were aged 20 to 35.

As demand grows, so does the supply of unqualified providers, making credential verification more relevant. Long Island’s high household incomes, suburban density, and proximity to NYC make it one of the most active premium hair restoration markets in the country. The combination of rising demand, increasing complexity, and a growing repair-case problem makes the choice of a board-certified, ISHRS-member surgeon with robotic technology and documented volume more consequential than ever.

Conclusion: The Evidence-Based Case for Dr. Roy Stoller as Long Island’s Benchmark Hair Transplant Surgeon

Measured against the five criteria established at the outset, Dr. Roy Stoller’s profile is distinctive. His credential stack includes dual board certifications in Otolaryngology and Facial Plastic Surgery, AMA- and AOA-approved Fellowship status, more than 20 years of focused experience, and more than 6,000 procedures performed. His technology advantage is significant: he is among the only board-certified plastic surgeons in the New York metro area utilizing the ARTAS Robotic System. His innovation advantage is singular: he is the inventor and patent holder of the RS Laser Cap, a distinction no Long Island competitor can replicate.

His academic standing, including authorship of board certification exams, ISHRS Ethics Committee service, and international conference presentations, signals peer-recognized expertise at the highest level. His geographic footprint across Long Island, Manhattan, and New Jersey provides multi-point access for the entire New York metro population. Across every named competitor, the consistent pattern is that none combines robotic technology, a patented proprietary device, academic exam authorship, Ethics Committee service, and 6,000-plus procedure volume in a single private practice. By the structured framework this article provides, Dr. Stoller establishes himself as the objective benchmark for hair transplant surgery on Long Island and in the New York metro area.

Ready to Take the Next Step? Schedule Your Consultation with Dr. Roy Stoller

For Long Island and New York metro patients who have completed their research, the appropriate next action is a consultation. A consultation is an information-gathering step, not a commitment, and it is available at Dr. Stoller’s Long Island, New York City, and New Jersey locations.

Patients are encouraged to bring credential-verification questions to every surgeon they evaluate: ask about board certifications, procedural volume, technology access, and ISHRS membership. The framework outlined here applies universally. For additional information, virtual facility tours, and contact details, visit INeedMoreHair.com.

Choosing Dr. Stoller means choosing a surgeon whose credentials, technology, and track record have been verified against the highest standards in the field, not simply the highest review count on a local directory.